Correspondence on 'Predicting the risk of nodal disease with histological and molecular features in endometrial cancer: the prospective PROME trial' by Bogani et al.

MLA

Luzarraga Aznar, Ana, et al. “Correspondence on ‘Predicting the Risk of Nodal Disease with Histological and Molecular Features in Endometrial Cancer: The Prospective PROME Trial’ by Bogani et Al.” International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society, vol. 34, no. 10, Oct. 2024, p. 1659. EBSCOhost, https://doi.org/10.1136/ijgc-2024-005958.

APA

Luzarraga Aznar, A., Bebia, V., & Cabrera, S. (2024). Correspondence on “Predicting the risk of nodal disease with histological and molecular features in endometrial cancer: the prospective PROME trial” by Bogani et al. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society, 34(10), 1659. https://doi.org/10.1136/ijgc-2024-005958

Chicago

Luzarraga Aznar, Ana, Vicente Bebia, and Silvia Cabrera. 2024. “Correspondence on ‘Predicting the Risk of Nodal Disease with Histological and Molecular Features in Endometrial Cancer: The Prospective PROME Trial’ by Bogani et Al.” International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society 34 (10): 1659. doi:10.1136/ijgc-2024-005958.